Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity.

Auteurs : Berretta M, Dal Lago L, Tinazzi M, Ronchi A, La Rocca G, Montella L, Di Francia R, Facchini BA, Bignucolo A, Montopoli M
Jaar : 2022
Journal : Cancers (Basel)
Volume : 14

The Managing Advanced Cancer Pain Together (MACPT) conversation tool: an evaluation of use in clinical practice.

Auteurs : Quinn B, Laurent S, Dargan S, Lapuente M, Lüftner D, Drudge-Coates L, Palma MD, Dal Lago L, Flynn J, Panter C, Seesaghur A
Jaar : 2022
Journal : Pain Manag
Volume : 12
Pagina's : 435-446

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D).

Auteurs : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart M
Jaar : 2022
Journal : Breast Cancer Res Treat
Volume : 191
Pagina's : 225

Use of information and communication technologies (ICTs) in cancer multidisciplinary team meetings: an explorative study based on EU healthcare professionals.

Auteurs : Prades J, Coll-Ortega C, Dal Lago L, Goffin K, Javor E, Lombardo C, de Munter J, Ponce J, Regge D, Salazar R, Valentini V, Borras JM
Jaar : 2022
Journal : BMJ Open
Volume : 12
Pagina's : e051181

Evaluation of the Comprehensive Geriatric Assessment (CGA) tool as a predictor of postoperative complications following major oncological abdominal surgery in geriatric patients.

Auteurs : Penning Y, El Asmar A, Moreau M, Raspé J, Dal Lago L, Pepersack T, Donckier V, Liberale G
Jaar : 2022
Journal : PLoS One
Volume : 17
Pagina's : e0264790

Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.

Auteurs : Dal Lago L, Uwimana AL, Coens C, Vuylsteke P, Curigliano G, Brouwers B, Jagiello-Gruszfeld A, Altintas S, Tryfonidis K, Poncet C, Bottomley A, Sousa B, Brain E, Wildiers H
Jaar : 2022
Journal : J Geriatr Oncol
Volume : 13
Pagina's : 582-593

The efficacy of the American College of Surgeons Surgical Risk Calculator in the prediction of postoperative complications in oncogeriatric patients after curative surgery for abdominal tumors.

Auteurs : El Asmar A, Hafez K, Fauconnier P, Moreau M, Dal Lago L, Pepersack T, Donckier V, Liberale G
Jaar : 2022
Journal : J Surg Oncol
Volume : 126
Pagina's : 1359-1366

Frailty in older adults with cancer (Fabio Gomez, editor) - Part III : Breast cancer in older adults with frailty

Auteurs : Dal Lago L, De Caluwe A, Borghgraef C, Dumont L, Pepersack T
Jaar : 2022
Journal : Book
Volume : part III
Pagina's : 303 - 318

Tolerability and toxicity of trastuzumab or trastuzumab?+?lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).

Auteurs : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Jaar : 2021
Journal : Breast Cancer Res Treat
Volume : 185
Pagina's : 107-116

Sarcoidosis Versus Lymphoma?

Auteurs : Dal Lago L, Sarrand J, Woff E, Awada A, Vouche M, Pepersack T
Jaar : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pagina's : 002250

Targeted agents in older patients with gastrointestinal cancers - An overview.

Auteurs : Monteiro AR, Conde RS, Basto R, Sclafani F, Deleporte A, Hendlisz A, Dal Lago L
Jaar : 2021
Journal : J Geriatr Oncol
Volume : 12
Pagina's : 1240-1252

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.

Auteurs : Dumont L, Salaroli A, Dal Lago L, Gil T, Pepersack T
Jaar : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pagina's : 002425

Anti-HER2 therapy for breast cancer in older patients.

Auteurs : Goldner M, Franzoi MA, Dal Lago L, Pondé N
Jaar : 2020
Journal : Future Oncol
Volume : 16
Pagina's : 1393-1407

The added value of geriatric assessment in evaluating a patient's Health-Related Quality-of-Life: A study in ≥70-year-old early-stage invasive breast cancer patients.

Auteurs : Quinten C, Kenis C, Hamaker M, Coolbrandt A, Brouwers B, Dal Lago L, Neven P, Vuylsteke P, Debrock G, Van den Bulck H, Smeets A, Schöffski P, Wedding U, Wildiers H
Jaar : 2020
Journal : Eur J Cancer Care (Engl)
Volume : 29
Pagina's : e13278

Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.

Auteurs : Klastersky J, Dal Lago L, Lalami Y
Jaar : 2020
Journal : Curr Opin Oncol
Volume : 32
Pagina's : 258-261

Targeted therapy for breast cancer in older patients.

Auteurs : Pondé N, Wildiers H, Awada A, de Azambuja E, Deliens C, Dal Lago L
Jaar : 2020
Journal : J Geriatr Oncol
Volume : 11
Pagina's : 380-388

Rare Features of Dermatomyositis in a Patient with Ovarian Cancer.

Auteurs : Dal Lago L, Vandergheynst F, Awada A, Pepersack T
Jaar : 2020
Journal : Eur J Case Rep Intern Med
Volume : 7
Pagina's : 001946

HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology.

Auteurs : Brain E, Caillet P, de Glas N, Biganzoli L, Cheng K, Dal Lago L, Wildiers H
Jaar : 2019
Journal : J Geriatr Oncol
Volume : 10
Pagina's : 1003-1013

Advances in pain management for older patients with cancer.

Auteurs : Hachem GE, Rocha FO, Pepersack T, Jounblat Y, Drowart A, Dal Lago L
Jaar : 2019
Journal : Ecancermedicalscience
Volume : 13
Pagina's : 980

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.

Auteurs : Wildiers H, Tryfonidis K, Dal Lago L, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Altintas S, Touati N, Cardoso F, Brain E
Jaar : 2018
Journal : Lancet Oncol
Volume : 19
Pagina's : 323-336